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Objectives. This study aims to report our experience in the management of HNBCC in ethnic Chinese over a 10-year period.
Methods. A retrospective review of all ethnic Chinese patients with HNBCC treated in a tertiary centre from 1999 to 2009. Results.
From 1999 to 2009, 225 patients underwent surgical excision for HNBCC. Majority were elderly female patients. Commonest
presentation was a pigmented (76.2%) ulcer (64.8%) over the nose (31.6%). Median skin margin taken on tumour excision was
2.0mm; primary skin closure was achieved in 51.8%. Postresection skin margin was clear in 75.4%. Of those with inadequate
skin margins, 56.7% opted for further treatment, 43.4% for observation. Recurrence rates were 2.6% and 13.8%, respectively
(P = 0.106). Overall recurrence rate was 5.5%. Conclusions. HNBCC commonly presented as pigmented ulcers over the nose of
elderly female patients in our locality. Adequate tumour excision ± reconstruction oﬀered the best chance of cure. Reexcision of
those with inadequate skin margins improved local tumour control.
1.Introduction
The incidence of skin cancer is increasing worldwide,
possibly arising from an ageing population and increasing
sunlight exposure. Basal cell carcinoma (BCC) is the most
prevalent. The incidence of which is increasing at 3% per
annum [1–7].
BCC most often arise in areas of long-term sun exposure
with a high predilection for the head and neck area. Classical
clinical features include raised and rolled edges, pearly
central area with telangiectasia. Lesions may be pigmented
or nonpigmented; nodular, ulcerative, erythematous patches
or even mimic benign lesions. Most BCCs are indolent with
a low incidence of metastasis [8–11].
The mainstay of treatment for BCC of the head and neck
region (HNBCC) is surgical excision with adequate margins.
Radiotherapy may be advocated as deﬁnitive treatment for
a selected group of patients, for those unﬁt for surgery
or as an adjuvant treatment for those with inadequate
margins. Other treatment modalities such as curettage and
electrodessication,cryosurgeryhavebeenreportedwithvari-
able treatment outcomes; similarly, topical and intralesional
agents, photodynamic therapy have also been described,
again with variable outcomes, warranting careful patient
selection [11–14].
Much has been published regarding BCCs in Caucasian
populations, but data on ethnic Chinese are less read-
ily available. We herein report the patient demographics,
tumour characteristics, surgical management, and outcome
of HNBCCs in ethnic Chinese patients in Hong Kong.
2.MaterialsandMethods
A retrospective review of all ethnic Chinese patients with
previously untreated HNBCC managed in the Queen Mary
Hospital, The University of Hong Kong, Hong Kong,
between 1999 and 2009. Queen Mary Hospital was one
of the largest regional hospitals in Hong Kong. It was
a tertiary and quaternary referral centre for the entire2 International Journal of Surgical Oncology
territory.Outcomemeasuresincludedpatientdemographics,
tumour characteristics, surgical management, management
of patients with inadequate margins, and recurrence rates.
Statistical analysis was performed using SPSS 18.0.
3. Results
3.1. Patient Demographics. A total of 226 HNBCC patients
of Chinese ethnicity were treated in our centre from 1999
to 2009. Mean age was 73.1 (22–100) years. There were 132
female and 94 male patients with a male to female ratio of
0.7. 25 patients had multiple BCC lesions. There were a total
of 273 HNBCC lesions.
3.2. Tumour Characteristics. There were 65 (23.8%) non-
pigmented and 208 (76.2%) pigmented lesions. The most
common presentation was in the form of an ulcer (64.8%,
n = 177), followed by nodule (19.3%, n = 53), erythema
(1.1%, n = 3), and lesions that mimic a benign lesion, for
example, keratosis (14.7%, n = 40) (Figure 1). Common
sites of involvement included the nose (31.6%, n = 86) and
cheek (16.5%, n = 45) (Figure 2).
3.3. Management. Onepatient withsolitaryHNBCC refused
treatment. All others underwent surgical excision. Median
skin margin taken on tumour excision was 2.0 (0–20)mm.
Primaryskinclosurewasachievedin51.8%(n = 141).Other
patients required reconstruction in the form of skin graft
(11.7%, n = 32), local ﬂap (35.3%, n = 96), and free ﬂap
(1.1%, n = 3) (Figure 3).
3.4. Treatment Outcomes. Skin margins were uninvolved,
involved, and close in 75.4% (n = 205), 15.4% (n = 42),
and9.2%(n = 25),respectively,withcloseskinmarginbeing
deﬁned as a pathological margin of less than one millimeter.
Involved and close skin margins were classiﬁed as inadequate
skin margins. The rate of tumour clearance was increased
with an increase in skin margin taken on tumour excision—
25.3%(n = 40)inadequatemarginsfor2mmmarginsversus
16.9% (n = 13) for 3mm margins (P = 0.089) (Figure 4).
Most patients with involved margins (76.2%, n = 32)
underwent reexcision; 4 (9.5%) underwent radiation ther-
apy. One developed local recurrence 2 years after reexcision.
The majority of those with close margins (92.0%, n =
23) opted for observation. Four developed local recurrence
thereafter. Two patients opted for reexcision, and none
recurred to date (Figure 5).
Further treatment in the form of reexcision or radiation
therapy in those with inadequate skin margins led to a lower
recurrence rate than those who opted for observation (2.6%
versus 13.8%, P = 0.106) (Figure 6) .F o l l o w - u pp e r i o dw a s
indeﬁnite for all patients. Overall recurrence rate was 5.5%
(n = 15) over a mean follow-up period of 73.0 (16–195)
months.Meanintervaltorecurrencewas36.6(9–78)months
(Figure 7). The commonest site of recurrence was over the
nose 20% (n = 3).
(a)
(b)
(c)
Figure 1: Common presentation of HNBCC in ethnic Chinese:
pigmented lesion with well-deﬁned borders, rolled ulcer edges,
central pearly area, and overlying telangiectasia.
4. Discussion
According to the Hong Kong Hospital Authority statistical
report 2007-2008, there was an increasing trend of skin
cancer in Hong Kong [15]. The rate of increase in skin
cancer and BCC incidence in ethnic Chinese and other Asian
countries was less than that of the fair-skinned Caucasian
population [16].
BCC had a high predilection for the head and neck
region. HNBCC predominantly aﬀected the elderly popu-
lation with a slight female preponderance in our locality.
Common presentation was in the form of a pigmented ulcer
over the nose.
Our results were similar to those reported by Sng et
al., Kikuchi et al., and Cho et al. [6, 17, 18]. This study,
corroborated by reviews in other Asian countries, showed
that HNBCC in ethnic Chinese and other Asian populationsInternational Journal of Surgical Oncology 3
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Figure 2: HNBCC presentation—anatomical sites. The commonest site was on the nose.
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Figure 3: Methods of wound closure. From right to left in a clockwise direction: an 80-year-old lady with a pigmented ulcerative BCC over
her left cheek, pathology excised with a 2mm margins, wound closed primarily; a 60-year-old lady with a pigmented ulcerative BCC over
her right preauricular region, the wound was too extensive for primary closure after tumour resection, and yet there was insuﬃcient tissue
for local ﬂap reconstruction, hence a full thickness skin graft was harvested from the postauricular region for wound coverage; a 70-year-old
lady with a nonpigmented nodular BCC over her nose tip. Excision was performed with a 2mm margin followed by reconstruction with a
bilobed ﬂap; a 50-year-old lady who presented with a pigmented ulcerative BCC over her right auricle which invaded into the superﬁcial and
deep lobes of the parotid gland; facial nerve was intact. Wide local excision of tumour with total conservative parotidectomy was performed.
The defect was reconstructed with a free anterolateral thigh myocutaneous ﬂap.4 International Journal of Surgical Oncology
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Figure 4: Treatment outcome—the greater the skin margin taken on tumour excision, the better the tumour clearance rate.
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Figure 5: Management of patients with involved and close margins and associated recurrence rates.
presented diﬀerently compared to the Caucasian population,
whereby HNBCC commonly presented as nonpigmented
nodules in male patients (Table 1)[ 6, 11, 17–19].
The diﬀerence in trends, rates, and presentation in the
two ethnic groups could be accounted for the diﬀerence in
skin types (Fitzpatrick types III and IV in Chinese versus
I and II in Caucasians), geographical latitude, sociocultural
diﬀerences, varying occupational and sun exposure, skin
protection, and diﬀerences in disease awareness and surveil-
lance.
There is no consensus as to the amount of skin margin
taken on tumour excision. However, as one would expect,
the greater the skin margin taken on tumour excision, the
better the tumour control. In excising tumour over the
head and neck region, there is always a balance between
adequate tumour control and conservation of normal tissue
in an attempt to achieve acceptable functional and cosmetic
outcome. Excision of HNBCC with a 2mm skin margin for
well-deﬁned lesions was adequate in most cases, with an
overall recurrence rate of 5.5%, which was comparable to
that of large-scale studies conducted worldwide [20–23].
As cited in other reviews, our data also showed that the
nosewasthesitewiththehighestincidenceofrecurrenceand
inadequate margins. This could represent embryonic fusion
planes where tumour can spread aggressively or because of
a scarcity of surplus skin tissue which may present technical
diﬃculty on skin closure, resulting in a more conservative
excision margin [24–27].
For such diﬃcult mid-face lesions, excision under frozen
section guidance or even Mohs micrographic surgery couldInternational Journal of Surgical Oncology 5
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Figure 6: Treatment outcomes of patients who chose to undergo further treatment versus observation in those with inadequate margins.
Table 1: A table comparing our results with other Asian and Caucasian populations.
Hong Kong (QMH)
N = 273
Singapore
N = 292
Japan
N = 243
Korea
N = 78
Australia
N = 6252
Mean age (yrs) 73.1 70.9 59.0 58.2 62.0
M:F 0.70 0.95 0.97 0.90 1.13
Clinical features Pigmented (76.2%) Pigmented (63%) Pigmented (75%) Pigmented (55%) Nonpigmented (93%)
Ulcer (64.8%) Ulcer (NA) Nodule (NA) Ulcer (NA) Nodule (50%)
Site Nose (32.3%) Nose (37.0%) Nose (NA) Nose (26.9%) Nose (40.6%)
Time( months)
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Figure 7: A graph depicting tumour recurrence over time.
be advocated to enhance complete tumour removal whilst
preserving the maximal amount of normal tissue [11, 19, 23,
28–30]. Various reconstructive techniques such as skin graft,
local ﬂaps, or even free ﬂaps could be used for skin coverage
if the defect is too extensive for primary closure.
In cases of inadequate skin margins, reexcision should be
advocated to prevent recurrence and to decrease the chance
of more radical surgery in the future; incompletely excised
tumour and recurrent tumours are contributing factors to
more aggressive tumour behaviour. The presence of scar
tissue obscures monitoring and delays clinical detection.
Fibrotic scar tissue entraps malignant cells and favours deep
extension by preventing upward migration [27, 31, 32].
5. Conclusions
HNBCC commonly presented as pigmented ulcers over the
cheekandnoseofelderlyfemalepatientsofChineseethnicity
in our locality. This corroborated with studies conducted in
other Asian countries but contrastedwith those of Caucasian
populations in that HNBCC commonly presented as non-
pigmented nodules in the male population. Tumour excision
with a 2mm skin margin for HNBCC with well-deﬁned
margins yielded a tumour control rate comparable with
other large-scale studies. Various reconstructive techniques
could be adapted in cases where primary skin closure could
not be achieved after adequate tumour resection. Reexcision
of lesions with inadequate margins improved local tumour
control.6 International Journal of Surgical Oncology
Conﬂict of Interests
The authors declare that there is no conﬂict of interests.
References
[1] American Cancer Society, “Detailed guide: skin cancer–basal
and squamous cell”.
[2] Cancer Research UK, “CancerStats Key facts on skin cancer.
H o wc o m m o ni ss k i nc a n c e r ? ”http://info.cancerresearchuk
.org/cancerstats/types/skin/#incidence.
[3] A. Katalinic, U. Kunze, and T. Sch¨ afer, “Epidemiology of
cutaneous melanoma and non-melanoma skin cancer in
Schleswig-Holstein, Germany: incidence, clinical subtypes,
tumourstagesandlocalization(epidemiologyofskincancer),”
British Journal of Dermatology, vol. 149, no. 6, pp. 1200–1206,
2003.
[4] M. P. Staples, M. Elwood, R. C. Burton, J. L. Williams,
R. Marks, and G. G. Giles, “Non-melanoma skin cancer in
Australia: the 2002 national survey and trends since 1985,”
Medical Journal of Australia, vol. 184, no. 1, pp. 6–10, 2006.
[ 5 ]R .C .H a y e s ,S .L e o n f e l l n e r ,W .P i l g r i m ,J .L i u ,a n dD .N .
Keeling, “Incidence of nonmelanoma skin cancer in New
Brunswick, Canada, 1992 to 2001,” Journal of Cutaneous
Medicine and Surgery, vol. 11, no. 2, pp. 45–52, 2007.
[6] J. Sng, D. Koh, W. C. Siong, and T. B. Choo, “Skin cancer
trends among Asians living in Singapore from 1968 to 2006,”
Journal of the American Academy of Dermatology, vol. 61, no.
3, pp. 426–432, 2009.
[7] B.L.DiﬀeyandJ.A.A.Langtry,“Skincancerincidenceandthe
ageing population,” British Journal of Dermatology, vol. 153,
no. 3, pp. 679–680, 2005.
[8] T. M. R¨ unger, “How diﬀerent wavelengths of the ultraviolet
spectrum contribute to skin carcinogenesis: the role of cellular
damage responses,” J o u r n a lo fI n v e s t i g a t i v eD e r m a t o l o g y , vol.
127, no. 9, pp. 2103–2105, 2007.
[9] A. J. Ridley, J. R. Whiteside, T. J. McMillan, and S. L. Allinson,
“Cellular and sub-cellular responses to UVA in relation to
carcinogenesis,”InternationalJournalofRadiationBiology,vol.
85, no. 3, pp. 177–185, 2009.
[10] S. Rosso, R. Zanetti, C. Martinez et al., “The multicentre south
European study ’Helios’ II: diﬀerent sun exposure patterns in
the aetiology of basal cell and squamous cell carcinomas of the
skin,” British Journal of Cancer, vol. 73, no. 11, pp. 1447–1454,
1996.
[11] V.Madan,J.T.Lear,andR.M.Szeimies,“Non-melanomaskin
cancer,” The Lancet, vol. 375, no. 9715, pp. 673–685, 2010.
[ 1 2 ]L .M .G o o d ,M .D .M i l l e r ,a n dW .A .H i g h ,“ I n t r a l e s i o n a l
agentsinthemanagementofcutaneousmalignancy:areview,”
Journal of the American Academy of Dermatology, vol. 64, no.
2, pp. 413–422, 2011.
[13] W. E. Love, J. D. Bernhard, and J. S. Bordeaux, “Topical
imiquimod or ﬂuorouracil therapy for basal and squamous
cell carcinoma: a systematic review,” Archives of Dermatology,
vol. 145, no. 12, pp. 1431–1438, 2009.
[14] E. S. Marmur, C. D. Schmults, and D. J. Goldberg, “A review
of laser and photodynamic therapy for the treatment of
nonmelanoma skin cancer,” Dermatologic Surgery, vol. 30, no.
2, pp. 264–271, 2004.
[15] Hospital Authority Statistical Report (2007–2008).
[16] D. Koh, H. Wang, J. Lee, K. S. Chia, H. P. Lee, and C. L.
Goh, “Basal cell carcinoma, squamous cell carcinoma and
melanoma of the skin: analysis of the Singapore Cancer
Registry data 1968–97,” British Journal of Dermatology, vol.
148, no. 6, pp. 1161–1166, 2003.
[17] A. Kikuchi, H. Shimizu, and T. Nishikawa, “Clinical and
histopathological characteristics of basal cell carcinoma in
Japanese patients,” Archives of Dermatology, vol. 132, no. 3, pp.
320–324, 1996.
[18] S. Cho, M. H. Kim, K. K. Whang, and J. H. Hahm, “Clinical
and histopathological characteristics of basal cell carcinoma
in Korean patients,” Journal of Dermatology, vol. 26, no. 8, pp.
494–501, 1999.
[19] I. Leibovitch, S. C. Huilgol, D. Selva, S. Richards, and R. Paver,
“Basal cell carcinoma treated with Mohs surgery in Australia
I. Experience over 10 years,” Journal of the American Academy
of Dermatology, vol. 53, no. 3, pp. 445–451, 2005.
[20] M. A. Bisson, C. Dunkin, R. W. Griﬃt h s ,a n dS .K .S u v a r n a ,
“Do plastic surgeons resect basal cell carcinomas too widely?
A prospective study comparing surgical and histological
margins,” British Journal of Plastic Surgery,v o l .5 5 ,n o .4 ,p p .
293–297, 2002.
[21] R. W. Griﬃths, S. K. Suvarna, and J. Stone, “Do basal
cell carcinomas recur after complete conventional surgical
excision?” British Journal of Plastic Surgery,v o l .5 8 ,n o .6 ,p p .
795–805, 2005.
[22] R. W. Griﬃths, S. K. Suvarna, and J. Stone, “Basal cell
carcinoma histological clearance margins: an analysis of 1539
conventionally excised tumours. Wider still and deeper?”
Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 60,
no. 1, pp. 41–47, 2007.
[23] K. Mosterd, G. A. Krekels, F. H. Nieman et al., “Surgical
excision versus Mohs’ micrographic surgery for primary and
recurrent basal-cell carcinoma of the face: a prospective
randomised controlled trial with 5-years’ follow-up,” The
Lancet Oncology, vol. 9, no. 12, pp. 1149–1156, 2008.
[24] C. A. Gooding, G. White, and M. Yatsuhashi, “Signiﬁcance of
marginal extension in excised basal-cell carcinoma,” The New
England Journal of Medicine, vol. 273, no. 17, pp. 923–924,
1965.
[25] R. R. Pascal, L. W. Hobby, R. Lattes, and G. F. Crikelair, “Prog-
nosis of ’incompletely excised’ versus ’completely excised’
b a s a lc e l lc a r c i n o m a , ”Plastic and Reconstructive Surgery, vol.
41, no. 4, pp. 328–332, 1968.
[26] L. Koplin and H. A. Zarem, “Recurrent basal cell carcinoma.
A review concerning the incidence, behaviour, and manage-
ment of recurrent basal cell carcinoma, with emphasis on
the incompletely excised lesion,” Plastic and Reconstructive
Surgery, vol. 65, no. 5, pp. 656–664, 1980.
[27] J. D. Richmond and R. M. Davie, “The signiﬁcance of
incomplete excision in patients with basal cell carcinoma,”
BritishJournalofPlasticSurgery,vol.40,no.1,pp.63–67,1987.
[28] N. W. J. Smeets, D. I. M. Kuijpers, P. Nelemans et al., “Mohs’
micrographic surgery for treatment of basal cell carcinoma of
the face—results of a retrospective study and review of the
literature,” British Journal of Dermatology, vol. 151, no. 1, pp.
141–147, 2004.
[29] E. P. Tierney and C. W. Hanke, “Cost eﬀectiveness of Mohs
micrographic surgery: review of the literature,” Journal of
Drugs in Dermatology, vol. 8, no. 10, pp. 914–922, 2009.
[30] I. Leibovitch, S. C. Huilgol, D. Selva, S. Richards, and R. Paver,
“Basal cell carcinoma treated with Mohs surgery in Australia
II. Outcome at 5-year follow-up,” J o u r n a lo ft h eA m e r i c a n
Academy of Dermatology, vol. 53, no. 3, pp. 452–457, 2005.International Journal of Surgical Oncology 7
[31] H. W. Walling, S. W. Fosko, P. A. Geraminejad, D. C.
Whitaker, and C. J. Arpey, “Aggressive basal cell carcinoma:
presentation, pathogenesis, and management,” Cancer and
Metastasis Reviews, vol. 23, no. 3-4, pp. 389–402, 2004.
[32] P. G. Lang and J. C. Maize, “Histologic evolution of recurrent
basal cell carcinoma and treatment implications,” Journal of
the American Academy of Dermatology, vol. 14, no. 2, pp. 186–
196, 1986.